Yearly Archives: 2023

/2023

Data Security & Protection Toolkit: 2023 PSNC guidance available

PSNC has published new guidance to help community pharmacy contractors to complete the 2022/23 Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Friday 30th June 2023. We recommend that contractors complete the Toolkit as soon as possible. We collaborated with NHS Digital to [...]

The post Data Security & Protection Toolkit: 2023 PSNC guidance available appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Data Security & Protection Toolkit: 2023 PSNC guidance available

Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Lenzetto® 1.53mg/dose transdermal spray is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Friday 13 January 2023. After this date, any prescriptions for Lenzetto® 1.53mg/dose transdermal spray must be dispensed [...]

The post Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Expiry of Lenzetto® 1.53mg/dose transdermal spray SSPs

Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited

CLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686 [...]

The post Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited appeared first on PSNC Website.

By |January 13th, 2023|Lexpos News|Comments Off on Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited

Minister comments on additional funding plea for pharmacy

In a statement to the House of Lords on Tuesday, Lord Markham, a Health Minister, talked about a ‘plan of using [pharmacies] more for patients [that] will put more funding their way’. He also went on to praise the sector saying they are a ‘crucial part of the front line’. This was in response to [...]

The post Minister comments on additional funding plea for pharmacy appeared first on PSNC Website.

By |January 12th, 2023|Lexpos News|Comments Off on Minister comments on additional funding plea for pharmacy

January video update from PSNC’s CEO

PSNC Chief Executive Janet Morrison has recorded a video update for community pharmacy contractors. The video looks back at some of the work and discussions with contractors that PSNC held in December, as well as looking to the year ahead. In the run up to Christmas the pressures on community pharmacy were immense – particularly [...]

The post January video update from PSNC’s CEO appeared first on PSNC Website.

By |January 11th, 2023|Lexpos News|Comments Off on January video update from PSNC’s CEO